ANOVA LAML specific result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 12:30:59 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: LAML specific
Individual drug analysis: 290
Drug details and screening numbers
Drug Name: KIN001-260
Drug ID: 290
Synonyms: Bayer IKKb inhibitor
Brand name:
Target: IKK
Number of cell lines screened: 921
Screening concentration range(s): 0.078125 to 20 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a4 |
NRAS_mut |
290 |
1 |
1 |
KIN001-260 |
IKK |
7 |
18 |
3 |
2.33 |
3.96 |
1.64 |
2.1 ** |
2.3 ** |
1.8 * |
1.37e-04 |
NA |
8.03e-02 |
2.9 |
All-tests volcano plot